BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2017
View Archived Issues
Kala Pharmaceuticals submits NDA for Inveltys to FDA
Read More
Roche reflects on accomplishments of third quarter 2017
Read More
Core lung cancer symptoms improved with dacomitinib in phase III trial
Read More
Novel Fc fusion GDF15 molecules for the treatment of obesity
Read More
Chugai files an application for additional indication for Perjeta in Japan
Read More
Assembly Biosciences presents phase Ia data for ABI-H0731
Read More
Zafgen compound ZGN-839 attenuates liver injury in NASH model
Read More
Ebola vaccine approved in China
Read More
Shionogi files for approval to manufacture and sell S-033188 in Japan
Read More
Neurocrine Biosciences begins T-Force GOLD study of Ingrezza in Tourette syndrome
Read More
FDA recognizes orphan drug exclusivity for Gocovri for dyskinesia in Parkinson's disease
Read More
GlaxoSmithKline patents novel BRD4 inhibitors
Read More
Medshine Discovery divulges EZH2 inhibitors
Read More
Roche and Genentech present ER-alpha modulators for breast cancer
Read More
PTC Therapeutics receives complete response letter for Translarna NDA
Read More
Tyme Technologies finds potential method and biomarker that could potentiate calcification of tumors
Read More
3R Valo discloses NO production inhibitors
Read More
Alopexx Vaccine completes phase I study of AV-0328
Read More
Cara Therapeutics doses first patient in study of CR-845
Read More
Shanghai Xunhe Pharmaceutical Technology divulges CDK4/6 inhibitors
Read More
FDA approves IND transfer of first TriKE, OXS-3550
Read More
Evotec and Tesaro announce immuno-oncology drug discovery collaboration
Read More
FDA grants fast track designation to Prometic's PBI-4050 for IPF
Read More
FREM/FRAS complex found to be behind CDH development
Read More
Essential tremor induced in Drosophila via KCNS2 gene overexpression
Read More
GSK announces pipeline highlights of third quarter 2017
Read More
Pulmocide initiates phase I study of inhaled PC-945
Read More